Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
USANA Health Sciences Inc
USNA | US
35.05
USD-0.80
-2.23%
USNA | US
About USANA Health Sciences Inc
Sector
Consumer Defensive
Industry
Household & Personal Products
Earnings date
30/06/2024
As of date
21/10/2024
Close
35.05
Open
35.76
High
35.76
Low
34.77
USANA Health Sciences Inc. develops manufactures and sells science-based nutritional personal care and skincare products. The company offers USANA nutritional products that comprise essentials/CellSentials such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular skeletal/structural and digestive health needs; and foods that include meal replacement shakes snack bars and other related products. It also provides Celavive a skin care regimen for various skin care types and ethnicities; and other products for prenatal infant and young child age groups. In addition the company offers materials and online tools to assist associates in building their businesses as well as in marketing products. It offers its products directly in the Asia Pacific the Americas and Europe as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences Inc. was founded in 1992 and is headquartered in Salt Lake City Utah.
View LessUSNA | US
Risk
27.3
Sharpe
-1.17
Luna's Score
33/100
Recommendation
Sell
Luna says (USNA | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
22.9%1 month
27.3%3 months
36.9%6 months
35.5%Returns
Fundamental Ratios
PE
12.54
Fwd. PE
11.75
Price to book
1.33
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
3.08
Ent. to rev.
0.41
PEG
0.98
Other Fundamentals
EBITDA
97.49M
MarketCap
667.78M
MarketCap(USD)
667.78M
Div. yield
-
Op. margin
8.38
Erngs. growth
-39.30
Rev. growth
-10.60
Ret. on equity
11.23
Short ratio
5.44
Short perc.
4.27
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
2.31
Range1M
4.21
Range3M
11.68
Volumes: Market Activity
Rel. volume
1.12
Price X volume
3.22M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 3.08 | 15.73 | Cheaper |
| Ent. to Revenue | 0.41 | 3.37 | Cheaper |
| PE Ratio | 12.54 | 36.94 | Cheaper |
| Price to Book | 1.33 | 38.40 | Cheaper |
| Dividend Yield | - | 3.29 | - |
| Std. Deviation (3M) | 36.87 | 53.54 | Lower Risk |
| Debt to Equity | - | 4.93 | - |
| Debt to Assets | - | 0.38 | - |
| Market Cap | 667.78M | 25.61B | Emerging |
